Multi Indocitra Tbk
PT Multi Indocitra Tbk engages in the trading of baby and health care products, and cosmetics in Indonesia. It is involved in the distribution, logistic services, warehousing, and transportation service; retail sale of baby; manufacturing baby products, such as nursing bottle, nipple, and baby accessories under Pigeon brand. In addition, the company provides e-commerce enabler and marketing agenc… Read more
Multi Indocitra Tbk (MICE) - Net Assets
Latest net assets as of September 2025: Rp966.55 Billion IDR
Based on the latest financial reports, Multi Indocitra Tbk (MICE) has net assets worth Rp966.55 Billion IDR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rp1.49 Trillion) and total liabilities (Rp524.46 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rp966.55 Billion |
| % of Total Assets | 64.83% |
| Annual Growth Rate | 18.7% |
| 5-Year Change | 36.27% |
| 10-Year Change | 58.85% |
| Growth Volatility | 33.79 |
Multi Indocitra Tbk - Net Assets Trend (2001–2024)
This chart illustrates how Multi Indocitra Tbk's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Multi Indocitra Tbk (2001–2024)
The table below shows the annual net assets of Multi Indocitra Tbk from 2001 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | Rp927.63 Billion | +4.15% |
| 2023-12-31 | Rp890.67 Billion | +18.91% |
| 2022-12-31 | Rp749.01 Billion | +5.41% |
| 2021-12-31 | Rp710.57 Billion | +4.39% |
| 2020-12-31 | Rp680.71 Billion | +0.27% |
| 2019-12-31 | Rp678.86 Billion | +6.45% |
| 2018-12-31 | Rp637.71 Billion | +4.99% |
| 2017-12-31 | Rp607.38 Billion | +1.09% |
| 2016-12-31 | Rp600.81 Billion | +2.88% |
| 2015-12-31 | Rp583.97 Billion | +9.87% |
| 2014-12-31 | Rp531.49 Billion | +7.28% |
| 2013-12-31 | Rp495.40 Billion | +46.06% |
| 2012-12-31 | Rp339.17 Billion | +10.78% |
| 2011-12-31 | Rp306.16 Billion | +7.16% |
| 2010-12-31 | Rp285.70 Billion | +13.39% |
| 2009-12-31 | Rp251.97 Billion | +8.31% |
| 2008-12-31 | Rp232.64 Billion | +6.55% |
| 2007-12-31 | Rp218.33 Billion | +11.98% |
| 2006-12-31 | Rp194.96 Billion | +22.56% |
| 2005-12-31 | Rp159.08 Billion | +160.60% |
| 2004-12-31 | Rp61.04 Billion | +50.82% |
| 2003-12-31 | Rp40.47 Billion | +46.05% |
| 2002-12-31 | Rp27.71 Billion | +54.21% |
| 2001-12-31 | Rp17.97 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Multi Indocitra Tbk's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 54469007800000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Rp544.69 Billion | 58.72% |
| Common Stock | Rp60.00 Billion | 6.47% |
| Other Comprehensive Income | Rp276.76 Billion | 29.84% |
| Other Components | Rp46.16 Billion | 4.98% |
| Total Equity | Rp927.61 Billion | 100.00% |
Multi Indocitra Tbk Competitors by Market Cap
The table below lists competitors of Multi Indocitra Tbk ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Odonate Inc.
PINK:ODTCD
|
$6.09 Million |
|
Lumos Diagnostics Holdings Limited
PINK:LDXHF
|
$6.09 Million |
|
Aman Agrindo
JK:GULA
|
$6.09 Million |
|
Enduro Metals Corporation
OTCQB:ENDMF
|
$6.09 Million |
|
Middlesex Water Company PFD 7%
PINK:MSEXP
|
$6.08 Million |
|
Aquaron Acquisition Corp. Common Stock
NASDAQ:AQU
|
$6.08 Million |
|
Resverlogix Corp.
PINK:RVXCF
|
$6.08 Million |
|
Nutrition SC PCL
BK:NTSC
|
$6.08 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Multi Indocitra Tbk's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 890,659,237,679 to 927,610,039,000, a change of 36,950,801,321 (4.1%).
- Net income of 42,125,321,000 contributed positively to equity growth.
- Dividend payments of 5,919,040,000 reduced retained earnings.
- Other comprehensive income increased equity by 744,519,768.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rp42.13 Billion | +4.54% |
| Dividends Paid | Rp5.92 Billion | -0.64% |
| Other Comprehensive Income | Rp744.52 Million | +0.08% |
| Other Changes | Rp553.00 | +0.0% |
| Total Change | Rp- | 4.15% |
Book Value vs Market Value Analysis
This analysis compares Multi Indocitra Tbk's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.32x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.52x to 0.32x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2007-12-31 | Rp328.30 | Rp500.00 | x |
| 2008-12-31 | Rp347.65 | Rp500.00 | x |
| 2009-12-31 | Rp378.06 | Rp500.00 | x |
| 2010-12-31 | Rp431.69 | Rp500.00 | x |
| 2011-12-31 | Rp458.00 | Rp500.00 | x |
| 2012-12-31 | Rp506.14 | Rp500.00 | x |
| 2013-12-31 | Rp738.91 | Rp500.00 | x |
| 2014-12-31 | Rp793.62 | Rp500.00 | x |
| 2015-12-31 | Rp885.99 | Rp500.00 | x |
| 2016-12-31 | Rp922.37 | Rp500.00 | x |
| 2017-12-31 | Rp1020.09 | Rp500.00 | x |
| 2018-12-31 | Rp1071.00 | Rp500.00 | x |
| 2019-12-31 | Rp1154.25 | Rp500.00 | x |
| 2020-12-31 | Rp1143.21 | Rp500.00 | x |
| 2021-12-31 | Rp1200.46 | Rp500.00 | x |
| 2022-12-31 | Rp1265.41 | Rp500.00 | x |
| 2023-12-31 | Rp1504.74 | Rp500.00 | x |
| 2024-12-31 | Rp1567.16 | Rp500.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Multi Indocitra Tbk utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 4.54%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.77%
- • Asset Turnover: 0.79x
- • Equity Multiplier: 1.53x
- Recent ROE (4.54%) is below the historical average (10.38%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2004 | 35.09% | 10.97% | 1.23x | 2.60x | Rp12.52 Billion |
| 2005 | 19.22% | 14.18% | 0.93x | 1.46x | Rp13.25 Billion |
| 2006 | 21.75% | 17.31% | 0.98x | 1.29x | Rp20.67 Billion |
| 2007 | 15.24% | 12.31% | 0.98x | 1.26x | Rp10.31 Billion |
| 2008 | 11.48% | 7.78% | 1.15x | 1.29x | Rp3.08 Billion |
| 2009 | 13.38% | 8.91% | 1.17x | 1.28x | Rp7.66 Billion |
| 2010 | 10.93% | 6.65% | 1.14x | 1.44x | Rp2.40 Billion |
| 2011 | 10.99% | 6.45% | 1.08x | 1.58x | Rp2.69 Billion |
| 2012 | 13.46% | 7.26% | 1.19x | 1.55x | Rp10.46 Billion |
| 2013 | 9.08% | 6.77% | 0.94x | 1.43x | Rp-4.04 Billion |
| 2014 | 8.15% | 7.31% | 0.80x | 1.40x | Rp-8.74 Billion |
| 2015 | 4.42% | 4.20% | 0.73x | 1.44x | Rp-29.52 Billion |
| 2016 | 3.79% | 3.24% | 0.76x | 1.55x | Rp-33.93 Billion |
| 2017 | 10.97% | 11.69% | 0.66x | 1.42x | Rp5.89 Billion |
| 2018 | 5.17% | 5.17% | 0.69x | 1.46x | Rp-30.77 Billion |
| 2019 | 5.39% | 5.05% | 0.71x | 1.51x | Rp-31.69 Billion |
| 2020 | 0.40% | 0.41% | 0.65x | 1.47x | Rp-65.37 Billion |
| 2021 | 4.24% | 3.91% | 0.72x | 1.50x | Rp-40.94 Billion |
| 2022 | 6.37% | 4.90% | 0.81x | 1.60x | Rp-27.19 Billion |
| 2023 | 3.86% | 3.16% | 0.82x | 1.49x | Rp-54.70 Billion |
| 2024 | 4.54% | 3.77% | 0.79x | 1.53x | Rp-50.64 Billion |
Industry Comparison
This section compares Multi Indocitra Tbk's net assets metrics with peer companies in the Household & Personal Products industry.
Industry Context
- Industry: Household & Personal Products
- Average net assets among peers: $1,574,162,617,461
- Average return on equity (ROE) among peers: 24.71%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Multi Indocitra Tbk (MICE) | Rp966.55 Billion | 35.09% | 0.54x | $6.09 Million |
| PT Estee Gold Feet Tbk (EURO) | $11.75 Billion | 25.81% | 0.88x | $103.51 Million |
| Falmaco Nonwoven Industri PT Tbk (FLMC) | $95.43 Billion | -58.47% | 1.06x | $1.33 Million |
| Martina Berto Tbk (MBTO) | $440.93 Billion | 2.00% | 0.61x | $2.33 Million |
| Mustika Ratu Tbk (MRAT) | $227.74 Billion | 13.81% | 0.22x | $2.57 Million |
| Mandom Indonesia Tbk (TCID) | $2.02 Trillion | 7.19% | 0.26x | $14.39 Million |
| Uni Charm Indonesia PT (UCID) | $4.91 Trillion | 9.78% | 0.59x | $20.94 Million |
| Unilever Indonesia Tbk (UNVR) | $4.48 Trillion | 170.75% | 3.47x | $683.14 Million |
| Victoria Care Indonesia Tbk Pt (VICI) | $416.69 Billion | 26.82% | 0.87x | $31.88 Million |